Epizyme, Inc.
Substituted purine compounds

Last updated:

Abstract:

The present invention relates to substituted purine compounds. The present invention also relates to pharmaceutical compositions containing these compounds and methods of treating disorders in which DOT1-mediated protein methylation plays a part, such as cancer, by administering these compounds and pharmaceutical compositions to subjects in need thereof.

Status:
Grant
Type:

Utility

Filling date:

23 Jun 2017

Issue date:

3 Sep 2019